Endocyte Begins Phase II Clinical Trial Of Ec145 For Treatment Of Women With Ovarian Cancer

Endocyte Inc. has announced the initiation of a randomized Phase II clinical study of the company's investigational drug EC145 in women with platinum-resistant ovarian cancer. The phase II trial, also called the "PRECEDENT study," will evaluate the efficacy and safety of EC145 when administered in combination with pegylated liposomal doxorubicin (PLD). PLD is widely used as a standard therapy for women with platinum-resistant ovarian cancer. Read more ...

Nanoscopic Changes To Pancreatic Cells Reveal Cancer

Nanoscopic Changes To Pancreatic Cells Reveal Cancer

A team of researchers in Chicago has developed a way to examine cell biopsies and detect never-before-seen signs of early-stage pancreatic cancer.

A team of researchers in Chicago has developed a way to examine cell biopsies and detect never-before-seen signs of early-stage pancreatic cancer, according to a new paper in the Optical Society (OSA) journal Optics Letters. Though the new technique has not yet proven effective in double-blind clinical trials, it may one day help diagnose cancers of the pancreas and, potentially, other organs at their earliest and most treatable stages, before they spread.

Source: 

Optical Society of America

Pollutants, Disease And Biological Weapons Detected By Tiny "Lab-On-A-Chip"

For centuries, animals have been our first line of defense against toxins. A canary in a coalmine served as a living monitor for poisonous gases. Scientists used fish to test for contaminants in our water. Even with modern advances, though, it can take days to detect a fatal chemical or organism. Until now. Working in the miniaturized world of nanotechnology, Tel Aviv University researchers have made an enormous - and humane - leap forward in the detection of pollutants. Read more ...